ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 215

External Hip Adduction Moment and Progression of Medial Tibiofemoral Cartilage Damage and Bone Marrow Lesions in Persons with Knee Osteoarthritis

Kirsten Moisio1, Alison H. Chang2, Ali Guermazi3, Joan S. Chmiel1, Orit Almagor1, Pottumarthi Prasad1, Yunhui Zhang1, Karen W. Hayes1, Laura Belisle1, Jamie Rayahin4 and Leena Sharma1, 1Northwestern University, Chicago, IL, 2Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, IL, 3Radiology, Boston University School of Medicine, Boston, MA, 4University of Illinois at Chicago, Chicago, IL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: gait and osteoarthritis, Knee, MRI

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Imaging and Biomechanics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Gait mechanics at the hip may affect medial joint loading at the knee in persons with knee OA. Greater external hip adduction moment (reflecting torque generation by hip abductor muscles) during gait may limit excessive hip drop or trunk lean. This, in turn, may prevent excessive medial knee joint loading and eventual progression of knee OA. Little is known about the relationship between hip adduction moment and progression of medial tibiofemoral OA by MRI. We hypothesized that greater baseline external hip adduction moment is associated with reduced risk of baseline-to-2-year progression of medial tibiofemoral cartilage damage and bone marrow lesions in persons with knee OA. Methods

Participants with knee OA, defined by osteophyte presence in at least one knee, underwent quantitative gait analysis at baseline. Both knees underwent 3.0T MRI at baseline and two year follow-up using double oblique coronal and axial FLASHwe, coronal T1weighted spinecho, and sagittal, axial and coronal fat suppressed turbo spin echo sequences. Cartilage damage and bone marrow lesions assessed using WORMS, blinding readers to hypotheses and all other data. Logistic regression with GEE used to account for correlation between limbs, assess the association between baseline hip adduction moment and baseline-to-2-year cartilage damage progression and bone marrow lesion progression, defined as any worsening of score in medial compartment or joint surface. Analyses adjusted for gait speed, age, gender, and disease severity (K/L grade). Results reported as ORs and 95% CIs. Results

204 persons [64.2 years (±9.9), BMI 28.5 kg/m2 (±5.7), 76.5% women] contributing 391 knees comprised the study sample. Mean hip adduction moment was 4.43 (±0.9) %BW*HT. Table 1 shows a greater hip adduction moment was significantly associated with reduced likelihood of cartilage damage progression in the medial tibiofemoral compartment and medial femoral surface. After adjustment for covariables, these associations were no longer significant. Table 2 shows means (SD) of the hip adduction moment at baseline for knees with/without cartilage damage and bone marrow lesion progression in specific subregions. Conclusion

In persons with knee OA, greater hip adduction moment was associated with reduced likelihood of 2-year medial tibiofemoral cartilage damage progression and bone marrow lesion progression, but findings were no longer significant in adjusted analyses. The consistently protective direction of findings at compartment, joint surface, and subregional levels warrants further evaluation at longer follow-up.

Table 1.  Unadjusted and adjusted ORs (95% CIs) for medial tibiofemoral OA progression at 2 years

Medial Tibiofemoral Compartment

Medial Femoral Surface

Medial Tibial Surface

Cartilage damage progression

Bone marrow lesion progression

Cartilage damage progression

Bone marrow lesion progression

Cartilage damage progression

Bone marrow lesion progression

Number of knees (%) with progression

61/391 (16%)

87/391 (22%)

48/391 (12%)

53/391 (14%)

29/391 (7%)

48/391 (12%)

Baseline predictor

External Hip Adduction Moment (%BW*HT)

Unadjusted

0.70

(0.51, 0.97)

0.75

(0.55, 1.01)

0.68

(0.50, 0.93)

0.72

(0.48, 1.08)

0.88

(0.59, 1.32)

0.96

(0.67, 1.37)

Adjusted*

0.82

(0.58, 1.15)

0.85

(0.61, 1.17)

0.79

(0.56, 1.12)

0.80

(0.53, 1.21)

1.07

(0.70, 1.64)

1.20

(0.83, 1.75)

Results are per 1 unit (%BW*HT) of external hip adduction moment (n=391 knees from 204 persons)

*adjusted for gait speed, age, gender, and K/L grade

Table 2.  Means (SD) for the external hip adduction moment in medial tibial and femoral subregions

External Hip Adduction Moment (%BW*HT), mean (SD)

Cartilage damage progression at 2-year follow-up

Posterior femur

Central femur

Posterior tibia

Central tibia

Anterior tibia

Number of knees (%) with progression

20/391 (5%)

33/391 (8%)

7/391 (2%)

25/391 (6%)

8/391 (2%)

Knees without progression, mean (SD)

4.45 (0.88)

4.44 (0.90)

4.43 (0.89)

4.43 (0.89)

4.43 (0.89)

Knees with progression, mean (SD)

3.97 (0.85)

4.36 (0.67)

3.98 (0.57)

4.32 (0.79)

4.61 (0.87)

Bone marrow lesion progression at 2-year follow-up 

Number of knees (%) with progression

19/391 (5%)

38/391 (10%)

12/391 (3%)

33/391 (8%)

21/391 (5%)

Knees without progression, mean (SD)

4.43 (0.87)

4.47 (0.87)

4.43(0.89)

4.44 (0.89)

4.43 (0.88)

Knees with progression, mean (SD)

4.38 (1.19)

4.05 (0.92)

4.38 (0.84)

4.34 (0.79)

4.52 (0.96)


Disclosure:

K. Moisio,
None;

A. H. Chang,
None;

A. Guermazi,

Shareholder of Boston Imaging Core LAb LLC,

5;

J. S. Chmiel,
None;

O. Almagor,
None;

P. Prasad,
None;

Y. Zhang,
None;

K. W. Hayes,
None;

L. Belisle,
None;

J. Rayahin,
None;

L. Sharma,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/external-hip-adduction-moment-and-progression-of-medial-tibiofemoral-cartilage-damage-and-bone-marrow-lesions-in-persons-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology